ViewRay (ViewRay) Float Percentage Of Total Shares Outstanding : 95.94% (As of May. 03, 2024)

View and export this data going back to 2014. Start your Free Trial

What is ViewRay Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ViewRay's float shares is 175.96 Mil. ViewRay's total shares outstanding is 183.40 Mil. ViewRay's float percentage of total shares outstanding is 95.94%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ViewRay's Insider Ownership is 5.99%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ViewRay's Institutional Ownership is 15.77%.

ViewRay Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

ViewRay's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	175.96	/	183.40
	=	95.94%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ViewRay (ViewRay) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ViewRay Inc (OTCPK:VRAYQ) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

1099 18th Street, Suite 3000, Denver, CO, USA, 80202

Website

https://www.viewray.com

ViewRay Inc is a radiation therapy and imaging technology company. It designs, manufactures, and markets radiation therapy systems that provide real-time imaging during radiation treatment. Its product portfolio encompasses The MRIdian linac system, The MRIdian system, the Monte Carlo treatment planning system, etc. The company holds the license for its combination of MRI and radiation therapy technologies. Geographically, it derives a majority of its revenue from the United States.

Executives

Karen Prange	director	1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316
B Kristine Johnson	director	366 FERNDALE RD S, WAYZATA MN 55391
Sanket Shah	officer: SVP, General Counsel	C/O VIEWRAY, INC., 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH 44146
Farhad Fred Ebrahimi	10 percent owner	191 UNIVERSITY BLVD., #246, DENVER CO 80206
Caley Castelein	director	THOM. WEISEL HEALTHCARE VENTURES, ONE MONTGOMERY STREET, SAN FRANCISCO CA 94104
Paul Jr Ziegler	officer: Chief Commercial Officer	C/O VIEWRAY, INC., 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH 44146
Scott William Drake	director, officer: President and CEO	9965 FEDERAL DRIVE, COLORADO SPRINGS CO 80921
Adam Andrew Podbelski	officer: SVP, Customer Services	C/O VIEWRAY, INC., 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH 44146
Jacob Edward Signoriello	officer: Chief Financial Officer	C/O VIEWRAY, INC., 1099 18TH STREET, SUITE 3000, DENVER CO 80202
James F. Dempsey	director, officer: Chief Scientific Officer	C/O VIEWRAY INCORPORATED, 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH 44146
Burke William P. Mr.	officer: Chief Financial Officer	HAEMONETICS CORPORATION, 400 WOOD ROAD, BRAINTREE MA 02184
Susan C Schnabel	director	C/O CREDIT SUISSE FIRST BOSTON, 11 MADISON AVE, NEW YORK NY 10010
Brian K Roberts	director	DIGITAS INC.,, 800 BOYLSTON STREET, BOSTON MA 02199
Zachary William Stassen	officer: Chief Financial Officer	C/O VIEWRAY, INC., 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH 44146
Daniel Jeffrey Moore	director	100 CYBERONICS BVLD, HOUSTON TX 77058